Steven Van Gucht - Infectious Diseases

Author Information

Steven Van Gucht is affiliated with the National Reference Center of Rabies, Viral Diseases, and Infectious Diseases in Humans at Sciensano, located in Brussels, Belgium. His research is primarily focused on infectious diseases, with significant contributions in the field of viral infections and public health.

Research Contributions

Steven Van Gucht has made notable contributions to the understanding and surveillance of viral diseases, particularly influenza and COVID-19. His work employs advanced genomic techniques to improve the detection and analysis of viral pathogens, enhancing public health responses. Key studies include the evaluation of reduced-dose COVID-19 vaccines, the effectiveness of serological tests for SARS-CoV-2, and the surveillance of non-influenza respiratory viruses. His research has also extended to rabies vaccination strategies in regions like Kinshasa, demonstrating a broad impact on global health initiatives.

Aliases

Steven Van Gucht is also known in the academic community by the aliases S Van Gucht and S. Van Gucht. These variations are frequently used in publications and citations.

Publication and Citation Metrics

Metric	Value
Publication Count	91
Citation Count	1928
H-index	24

Publications:

Whole-Genome Sequence Approach and Phylogenomic Stratification Improve the Association Analysis of Mutations With Patient Data in Influenza Surveillance

DOI: 10.3389/fmicb.2022.809887

Year: 2022

Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): a single blind, randomized, non-inferiority trial

DOI: 10.1101/2022.03.25.22272599

Year: 2022

No molecular detection of tick-borne pathogens in the blood of patients with erythema migrans in Belgium

DOI: 10.1186/s13071-021-05139-w

Year: 2022

Extending influenza surveillance to detect non-influenza respiratory viruses of public health relevance: analysis of surveillance data, 2015-2019, Belgium

DOI: 10.1101/2021.01.13.20202200

Year: 2021

Deepening of In Silico Evaluation of SARS-CoV-2 Detection RT-qPCR Assays in the Context of New Variants

DOI: 10.3390/genes12040565

Year: 2021

Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naiÌve residents of nursing homes

DOI: 10.1101/2021.06.08.21258366

Year: 2021

Evaluation of dog vaccination schemes against rabies in Kinshasa, Democratic Republic of the Congo.

DOI: 10.1016/j.prevetmed.2021.105531

Year: 2021

Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2

DOI: 10.1016/j.jcv.2021.104897

Year: 2021

Whole-genome-based phylogenomic analysis of the Belgian 2016–2017 influenza A(H3N2) outbreak season allows improved surveillance

DOI: 10.1099/mgen.0.000643

Year: 2021

Towards a European strategy to address the COVID-19 pandemic

DOI: 10.1016/S0140-6736(21)01808-0

Year: 2021

What is the Role of Artificial Intelligence in Infectious Diseases?

How Does the Immune System Recognize Pathogens?

What Role Do Host Proteins Play?

How Do Bacteria Become Resistant?

How is Zika Virus Diagnosed?

What is the Global Impact of Dengue?

What are the Symptoms of Rabies?

Why is Ventilation Important in Healthcare Settings?

What is the Innate Immune System?

What Are the Treatment Options for Infected Newborns?

Partnered Content Networks

Relevant Topics